SCI & TECH● LOWAug 7 · Aug 7, 2026, 9:45 AM
Pulse Biosciences targets early October enrollment completion for 164-patient NANOPULSE-AF study
Seeking Alpha Tech
Pulse Biosciences aims to complete patient enrollment for its 164-patient NANOPULSE-AF study by early October. This indicates progress in a clinical trial for medical technology.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH33m agoCSIR-NEERI Director Venkata Mohan elected INSA FellowThe HinduSCI & TECH39m agoAre EVs really bad for the environment?DW News [en]SCI & TECH43m agoApple makes biggest change to iPhone release cadence in 7 years in Ternus' first showcase as CEOCNBCSCI & TECH45m agoHow SiTime’s (SITM) Silicon Timing Devices Power AI Data CentersYahoo Finance